THYMIC CANCER

Clinical trials for THYMIC CANCER explained in plain language.

Never miss a new study

Get alerted when new THYMIC CANCER trials appear

Sign up with your email to follow new studies for THYMIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Terminated 1

Experimental drug targets rare thymus cancers after chemotherapy fails

Disease control Ongoing

This phase II trial tests bintrafusp alfa (M7824) in 9 adults with thymoma or thymic carcinoma that returned after platinum-based chemotherapy. Participants receive the drug intravenously every two weeks until their disease worsens or side effects become intolerable. The study ai…

Matched conditions: THYMIC CANCER

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

THYMIC CANCER

Get alerted when new THYMIC CANCER trials appear

Experimental drug targets rare thymus cancers after chemotherapy fails